Calamos Advisors’s MariaDB plc Warrants, each whole warrant exercisable for one Ordinary Share at an exercise price of $11.50 per share MRDB.WS Stock Holding History

Calamos Advisors’s Portfolio MRDB.WS Stock Details MRDB.WS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-166,666	Closed	-$21.2K	–	1017
2024 Q2	$21.2K	Hold	166,666	–	–	﹤0.01%	856
2024 Q1	$15K	Hold	166,666	–	–	﹤0.01%	874
2023 Q4	$7.08K	Hold	166,666	–	–	﹤0.01%	869
2023 Q3	$14.7K	Hold	166,666	–	–	﹤0.01%	845
2023 Q2	$24.2K	Hold	166,666	–	–	﹤0.01%	851
2023 Q1	$40.4K	Hold	166,666	–	–	﹤0.01%	949
2022 Q4	$59.7K	Buy	+166,666	New	+$65K	﹤0.01%	978

Calamos Advisors's MRDB.WS Position: Q3 2024 in Review

Calamos Advisors sold out of MariaDB plc Warrants, each whole warrant exercisable for one Ordinary Share at an exercise price of $11.50 per share (MRDB.WS) in Q3 2024, closing a stake of 166,666 shares — an estimated $21.2K sold.

Calamos Advisors first reported a position in MRDB.WS in Q4 2022 and held it in 7 quarters. The position peaked at $59.7K in Q4 2022. 0 funds tracked by Wall St. Rank hold MRDB.WS as of Q3 2024.

Calamos Advisors reported no remaining MariaDB plc Warrants, each whole warrant exercisable for one Ordinary Share at an exercise price of $11.50 per share position as of Q3 2024 after selling out during the quarter.
Calamos Advisors sold 166,666 MariaDB plc Warrants, each whole warrant exercisable for one Ordinary Share at an exercise price of $11.50 per share shares in Q3 2024, an estimated $21.2K.
Calamos Advisors first reported a position in MariaDB plc Warrants, each whole warrant exercisable for one Ordinary Share at an exercise price of $11.50 per share in Q4 2022 and held it in 7 quarters.
Calamos Advisors's MariaDB plc Warrants, each whole warrant exercisable for one Ordinary Share at an exercise price of $11.50 per share position peaked at $59.7K in Q4 2022.
0 funds tracked by Wall St. Rank held MariaDB plc Warrants, each whole warrant exercisable for one Ordinary Share at an exercise price of $11.50 per share as of Q3 2024.

Based on Calamos Advisors's 13F filing for Q3 2024, filed 7 Nov 2024.